UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 741

Sortiert nach

The need for specialized care for patients with Grown-up Congenital Heart Disease

European heart journal, 2017-03, Vol.38 (12), p.843-846

Breithardt, Günter

2017

Link zum Volltext

Verfügbarkeit prüfen

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

The New England journal of medicine, 2020-10, Vol.383 (14), p.1305-1316

2020

Link zum Volltext

Verfügbarkeit prüfen

Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure

Circulation (New York, N.Y.), 2021-09, Vol.144 (11), p.845-858

2021

Link zum Volltext

Verfügbarkeit prüfen

NOACs for Stroke Prevention in Atrial Fibrillation With Valve Disease: Filling the Gaps

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1383-1385

Breithardt, Günter

2017

Link zum Volltext

Verfügbarkeit prüfen

Age-and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice

Circulation (New York, N.Y.), 2006-10, Vol.114 (17), p.1799-1806

2006

Link zum Volltext

Verfügbarkeit prüfen

Historische Entwicklung der Diagnostik der bradykarden Rhythmusstörungen: Die frühen Jahre der Klinischen Elektrophysiologie in Deutschland

Herzschrittmachertherapie & Elektrophysiologie, 2024-03, Vol.35 (Suppl 1), p.5-17

Breithardt, Günter

2024

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

The New England journal of medicine, 2011-09, Vol.365 (10), p.883-891

2011

Link zum Volltext

Verfügbarkeit prüfen

Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial

European heart journal, 2022-03, Vol.43 (12), p.1219-1230

2022

Link zum Volltext

Verfügbarkeit prüfen

Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy

Journal of the American College of Cardiology, 2022-07, Vol.80 (4), p.283-295

2022

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study

Circulation (New York, N.Y.), 2023-01, Vol.147 (4), p.296-309

2023

Link zum Volltext

Verfügbarkeit prüfen

NOACs for Stroke Prevention in Atrial Fibrillation With Valve Disease

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1383-1385

Breithardt, Günter, MD

2017

Link zum Volltext

Verfügbarkeit prüfen

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

The Lancet (British edition), 2012-07, Vol.380 (9838), p.238-246

2012

Link zum Volltext

Verfügbarkeit prüfen

Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden

Circulation (New York, N.Y.), 2022-09, Vol.146 (11), p.836-847

2022

Link zum Volltext

Verfügbarkeit prüfen

Predisposing factors for atrial fibrillation in the elderly

Journal of geriatric cardiology : JGC, 2017-03, Vol.14 (3), p.179-184

2017

Link zum Volltext

Verfügbarkeit prüfen

Ludger Seipel: an early comer in clinical electrophysiology at 80 years

Clinical research in cardiology, 2020-04, Vol.109 (4), p.527-528

2020

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban for Stroke Prevention in East Asian Patients From the ROCKET AF Trial

Stroke (1970), 2014-06, Vol.45 (6), p.1739-1747

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET)

Europace (London, England), 2021-12, Vol.23 (12), p.1903-1912

2021

Link zum Volltext

Verfügbarkeit prüfen

Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial

Journal of the American College of Cardiology, 2013-05, Vol.61 (19), p.1998-2006

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)

The American journal of cardiology, 2017-08, Vol.120 (4), p.588-594

2017

Link zum Volltext

Verfügbarkeit prüfen

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

The Lancet (British edition), 2015-06, Vol.385 (9985), p.2363-2370

2015

Link zum Volltext

Verfügbarkeit prüfen

Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy

Nature genetics, 2004-11, Vol.36 (11), p.1162-1164

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 741

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(704)
Mit Volltextzugriff
(709)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(498)
Life Sciences & Biomedicine
(492)
Humans
(445)
Cardiovascular System & Cardiology
(419)
Cardiac & Cardiovascular Systems
(406)
Male
(317)
Female
(299)
Middle Aged
(234)
Biological And Medical Sciences
(187)
Aged
(185)
Medical Sciences
(184)
Adult
(147)
Cardiology. Vascular System
(128)
Heart
(124)
Electrocardiography
(108)
Animals
(90)
Atrial Fibrillation
(89)
Risk Factors
(84)
Cardiology And Cardiovascular Medicine
(83)
Treatment Outcome
(78)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

The need for specialized care for patients with Grown-up Congenital Heart Disease

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure

NOACs for Stroke Prevention in Atrial Fibrillation With Valve Disease: Filling the Gaps

Age-and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice

Historische Entwicklung der Diagnostik der bradykarden Rhythmusstörungen: Die frühen Jahre der Klinischen Elektrophysiologie in Deutschland

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial

Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy

A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF

NOACs for Stroke Prevention in Atrial Fibrillation With Valve Disease

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial

Predisposing factors for atrial fibrillation in the elderly

Ludger Seipel: an early comer in clinical electrophysiology at 80 years

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

Rivaroxaban for Stroke Prevention in East Asian Patients From the ROCKET AF Trial

Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET)

Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)

Suchergebnisse filtern